Use of Biosimilars in Pediatric Inflammatory Bowel Disease: An Updated Position Statement of the Pediatric IBD Porto Group of ESPGHAN

Journal of Pediatric Gastroenterology and Nutrition
Lissy de RidderPaediatric IBD Porto group of ESPGHAN

Abstract

Biologic therapies have changed the outcome of both adult and pediatric patients with Inflammatory Bowel Disease (IBD). In September 2013, the first biosimilar of infliximab was introduced into the pharmaceutical market. In 2015, a first position paper on the use of biosimilars in pediatric IBD was published by the ESPGHAN IBD Porto group. Since then, more data have accumulated for both adults and children demonstrating biosimilars are an effective and safe alternative to the originator. In this updated position statement, we summarize current evidence and provide joint consensus statements regarding the recommended practice of biosimilar use in children with IBD.

References

Feb 14, 2003·The New England Journal of Medicine·Filip BaertPaul Rutgeerts
Jun 14, 2003·Gastroenterology·Jan M H Van den BrandeSander J H van Deventer
Sep 22, 2011·Inflammatory Bowel Diseases·Charlotte I de BieLissy de Ridder
Mar 13, 2012·The AAPS Journal·Narendra ChirmuleBernd Meibohm
Jul 5, 2012·Annals of the Rheumatic Diseases·Pauline A van SchouwenburgDiana Wouters
Jan 16, 2013·Pediatrics·Marilyn J FieldThomas F Boat
Feb 13, 2013·Nature Reviews. Rheumatology·Pauline A van SchouwenburgGerrit Jan Wolbink
Apr 30, 2013·Journal of Crohn's & Colitis·Silvio DaneseUNKNOWN Governing Board and Operational Board of ECCO
Apr 12, 2014·European Journal of Gastroenterology & Hepatology·Tibor Hlavaty, Juraj Letkovsky
May 17, 2014·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Valentin BrodszkyMárta Péntek
Jun 26, 2014·Biologicals : Journal of the International Association of Biological Standardization·Brian G FeaganAnthony S Russell
Jun 1, 2011·Therapeutic Advances in Drug Safety·Michael G Tovey, Christophe Lallemand
Aug 21, 2014·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Vito AnneseUNKNOWN Italian Group for the Study of IBD (IG-IBD)
Oct 10, 2014·Blood·Martina WeiseChristian K Schneider
Dec 18, 2014·MAbs·Soon Kwan JungShin Jae Chang
Dec 23, 2014·Digestive Diseases·Fernando Gomollón
Feb 17, 2015·World Journal of Gastroenterology : WJG·Fanni RenczPeter L Lakatos
Jun 4, 2015·Current Opinion in Gastroenterology·Fernando Gomollón
Jun 17, 2015·Nature Reviews. Gastroenterology & Hepatology·Niels Vande Casteele, William J Sandborn
Jul 15, 2015·Journal of Pediatric Gastroenterology and Nutrition·Lissy de RidderUNKNOWN ESPGHAN Paediatric IBD Porto Group
Sep 24, 2015·Expert Review of Gastroenterology & Hepatology·Jørgen JahnsenPetr Ricanek
Nov 19, 2015·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Donghoon ShinRainard Fuhr
Feb 19, 2016·Journal of Pediatric Gastroenterology and Nutrition·Adam FrymoyerK T Park
Mar 12, 2016·Annals of the Rheumatic Diseases·M Begoña Ruiz-ArgüelloDaniel Nagore
Mar 24, 2016·Scandinavian Journal of Gastroenterology·Radan KeilJulius Špičák
Oct 30, 2016·Journal of Crohn's & Colitis·Klaudia FarkasTamás Molnár

❮ Previous
Next ❯

Citations

Dec 4, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Binita DuttaSteven Simoens
Aug 4, 2020·Journal of Clinical Pharmacy and Therapeutics·Valeria Dipasquale, Claudio Romano
Sep 10, 2020·Journal of the Canadian Association of Gastroenterology·Gilaad G KaplanRemo Panaccione
May 28, 2019·International Journal of Molecular Sciences·Martine A AardoomLissy de Ridder
Sep 14, 2020·Journal of Digestive Diseases·Saurabh Talathi, Kondal R Kyanam Kabir Baig
Dec 2, 2020·Journal of Personalized Medicine·Gregor JezernikUroš Potočnik
Feb 6, 2021·Journal of Clinical Pharmacy and Therapeutics·Xiao WangDa-Li Sun
Feb 12, 2021·Expert Opinion on Biological Therapy·Anurag S RathoreChinmoyee Maharana
Jun 28, 2021·Digestive Diseases and Sciences·Shubha BhatFrancis A Farraye
Aug 14, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Francesca PenaginiGian Vincenzo Zuccotti
Sep 22, 2021·Scandinavian Journal of Gastroenterology·Johanna LehtomäkiKaija-Leena Kolho
Oct 28, 2021·Drugs·Eduardo MyslerLaurent Peyrin-Biroulet
Oct 9, 2021·British Journal of Clinical Pharmacology·Nerea García-BelosoNoemí Martínez-López de Castro
Dec 18, 2021·Expert Opinion on Biological Therapy·Javier P GisbertGiampiero Girolomoni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved